In clinicopathologic features of 41 patients with HER2 amplified CRC, the patients consisted of twenty-four (58.5%) men and seventeen (41.5%) women (male to female ratio: 1.4), with a mean age of 60 years. Here, ERBB2 is linked to colorectal carcinoma.